Liquid-Absorbing Gauze Clots Wounds in Seconds
By HospiMedica International staff writers Posted on 28 Feb 2016 |
Image: Woundclot Hemostatic Gauze (Photo courtesy of Core Scientific Creations).
Innovative hemostatic gauze dissolves on site to manage bleeding from a variety of external wounds and traumatic injuries, as well as lacerations and abrasions.
WoundClot is a single-use, sterile, and bio-absorbable gauze made of non-oxidized cotton cellulose, which can be fabricated into a variety of forms and sizes. When exposed to water, blood, or exudates, the molecular structure changes to form a gelatinous membrane which adheres to the wound, thus creating a mechanical barrier which reduces blood flow immediately. Platelets from the natural clotting mechanism then attach via intermolecular forces to form a stable film that can withstand severe arterial and venous blood flow for hours.
Subsequently, specific molecular functional groups created during the manufacturing process and dispersed within the gel activate various coagulation factors in the blood, helping to form a natural biological fibrin clot in the wound. The stable yet flexible gel complex can retain its structural integrity for an extended period of time, which can be removed easily using water or saline. WoundClot is a product of Core Scientific Creations (CSC; Shave Zion, Israel), and has been approved by the US Food and Drug Administration (FDA).
“It comes in a long ribbon. When it is exposed to liquids, this product starts to absorb enormous amount of blood and then it transforms into a gel state,” said Shani Eliyahu-Gross, PhD, vice president and chief technological officer (CTO) of CSC. “The bandage not only stops otherwise unmanageable bleeding within minutes, it does it without the need to apply pressure, usually critical after certain wounds to areas like the neck or head; the more blood absorbed, the quicker the clotting process.”
Related Links:
Core Scientific Creations
WoundClot is a single-use, sterile, and bio-absorbable gauze made of non-oxidized cotton cellulose, which can be fabricated into a variety of forms and sizes. When exposed to water, blood, or exudates, the molecular structure changes to form a gelatinous membrane which adheres to the wound, thus creating a mechanical barrier which reduces blood flow immediately. Platelets from the natural clotting mechanism then attach via intermolecular forces to form a stable film that can withstand severe arterial and venous blood flow for hours.
Subsequently, specific molecular functional groups created during the manufacturing process and dispersed within the gel activate various coagulation factors in the blood, helping to form a natural biological fibrin clot in the wound. The stable yet flexible gel complex can retain its structural integrity for an extended period of time, which can be removed easily using water or saline. WoundClot is a product of Core Scientific Creations (CSC; Shave Zion, Israel), and has been approved by the US Food and Drug Administration (FDA).
“It comes in a long ribbon. When it is exposed to liquids, this product starts to absorb enormous amount of blood and then it transforms into a gel state,” said Shani Eliyahu-Gross, PhD, vice president and chief technological officer (CTO) of CSC. “The bandage not only stops otherwise unmanageable bleeding within minutes, it does it without the need to apply pressure, usually critical after certain wounds to areas like the neck or head; the more blood absorbed, the quicker the clotting process.”
Related Links:
Core Scientific Creations
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration